Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-01-15

AUTHORS

Byoung Chul Cho, Joong Bae Ahn, Jinsil Seong, Jae Kyung Roh, Joo Hang Kim, Hyun Cheol Chung, Joo Hyuk Sohn, Nam Kyu Kim

ABSTRACT

BackgroundThe objectives of this study were to evaluate long-term results of concurrent chemoradiotherapy (CRT) with 5-fluorouracil and cisplatin and the potential benefit of consolidation chemotherapy in patients with anal squamous cell carcinoma (ASCC).MethodsBetween January 1995 and February 2006, 31 patients with ASCC were treated with CRT. Radiotherapy was administered at 45 Gy over 5 weeks, followed by a boost of 9 Gy to complete or partial responders. Chemotherapy consisted of 5-fluorouracil (750 or 1,000 mg/m2) daily on days 1 to 5 and days 29 to 33; and, cisplatin (75 or 100 mg/m2) on day 2 and day 30. Twelve patients had T3–4 disease, whereas 18 patients presented with lymphadenopathy. Twenty-one (67.7%) received consolidation chemotherapy with the same doses of 5-fluorouracil and cisplatin, repeated every 4 weeks for maximum 4 cycles.ResultsNineteen patients (90.5%) completed all four courses of consolidation chemotherapy. After CRT, 28 patients showed complete responses, while 3 showed partial responses. After a median follow-up period of 72 months, the 5-year overall, disease-free, and colostomy-free survival rates were 84.7%, 82.9% and 96.6%, demonstrating that CRT with 5-fluorouracil and cisplatin yields a good outcome in terms of survival and sphincter preservation. No differences in 5-year OS and DFS rates between patients treated with CRT alone and CRT with consolidation chemotherapy was observed.Conclusionour study shows that CRT with 5-FU and cisplatin, with or without consolidation chemotherapy, was well tolerated and proved highly encouraging in terms of long-term survival and the preservation of anal function in ASCC. Further trials with a larger patient population are warranted in order to evaluate the potential role of consolidation chemotherapy. More... »

PAGES

8

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2407-8-8

DOI

http://dx.doi.org/10.1186/1471-2407-8-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049557045

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18194582


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anus Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Radiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea", 
            "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cho", 
        "givenName": "Byoung Chul", 
        "id": "sg:person.013035643562.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013035643562.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea", 
            "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahn", 
        "givenName": "Joong Bae", 
        "id": "sg:person.010673374672.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010673374672.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea", 
            "Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seong", 
        "givenName": "Jinsil", 
        "id": "sg:person.0772340340.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772340340.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea", 
            "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roh", 
        "givenName": "Jae Kyung", 
        "id": "sg:person.0767622633.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea", 
            "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Joo Hang", 
        "id": "sg:person.012631625664.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012631625664.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea", 
            "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "Hyun Cheol", 
        "id": "sg:person.016554426212.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea", 
            "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sohn", 
        "givenName": "Joo Hyuk", 
        "id": "sg:person.0661267733.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661267733.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Nam Kyu", 
        "id": "sg:person.01034544570.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034544570.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6601378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007692399", 
          "https://doi.org/10.1038/sj.bjc.6601378"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-01-15", 
    "datePublishedReg": "2008-01-15", 
    "description": "BackgroundThe objectives of this study were to evaluate long-term results of concurrent chemoradiotherapy (CRT) with 5-fluorouracil and cisplatin and the potential benefit of consolidation chemotherapy in patients with anal squamous cell carcinoma (ASCC).MethodsBetween January 1995 and February 2006, 31 patients with ASCC were treated with CRT. Radiotherapy was administered at 45 Gy over 5 weeks, followed by a boost of 9 Gy to complete or partial responders. Chemotherapy consisted of 5-fluorouracil (750 or 1,000 mg/m2) daily on days 1 to 5 and days 29 to 33; and, cisplatin (75 or 100 mg/m2) on day 2 and day 30. Twelve patients had T3\u20134 disease, whereas 18 patients presented with lymphadenopathy. Twenty-one (67.7%) received consolidation chemotherapy with the same doses of 5-fluorouracil and cisplatin, repeated every 4 weeks for maximum 4 cycles.ResultsNineteen patients (90.5%) completed all four courses of consolidation chemotherapy. After CRT, 28 patients showed complete responses, while 3 showed partial responses. After a median follow-up period of 72 months, the 5-year overall, disease-free, and colostomy-free survival rates were 84.7%, 82.9% and 96.6%, demonstrating that CRT with 5-fluorouracil and cisplatin yields a good outcome in terms of survival and sphincter preservation. No differences in 5-year OS and DFS rates between patients treated with CRT alone and CRT with consolidation chemotherapy was observed.Conclusionour study shows that CRT with 5-FU and cisplatin, with or without consolidation chemotherapy, was well tolerated and proved highly encouraging in terms of long-term survival and the preservation of anal function in ASCC. Further trials with a larger patient population are warranted in order to evaluate the potential role of consolidation chemotherapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2407-8-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "anal squamous cell carcinoma", 
      "concurrent chemoradiotherapy", 
      "consolidation chemotherapy", 
      "squamous cell carcinoma", 
      "long-term results", 
      "cell carcinoma", 
      "colostomy-free survival rates", 
      "T3-4 disease", 
      "larger patient population", 
      "long-term survival", 
      "terms of survival", 
      "ResultsNineteen patients", 
      "median follow", 
      "sphincter preservation", 
      "DFS rates", 
      "anal function", 
      "partial responders", 
      "partial response", 
      "complete response", 
      "patient population", 
      "same doses", 
      "further trials", 
      "BackgroundThe objective", 
      "day 29", 
      "chemotherapy", 
      "ConclusionOur study", 
      "patients", 
      "better outcomes", 
      "day 1", 
      "day 2", 
      "survival rate", 
      "day 30", 
      "cisplatin", 
      "chemoradiotherapy", 
      "potential role", 
      "carcinoma", 
      "weeks", 
      "survival", 
      "potential benefits", 
      "lymphadenopathy", 
      "radiotherapy", 
      "follow", 
      "responders", 
      "disease", 
      "doses", 
      "trials", 
      "months", 
      "response", 
      "Overall", 
      "outcomes", 
      "study", 
      "rate", 
      "preservation", 
      "population", 
      "course", 
      "period", 
      "differences", 
      "role", 
      "benefits", 
      "objective", 
      "results", 
      "boost", 
      "function", 
      "cycle", 
      "terms", 
      "order", 
      "yield"
    ], 
    "name": "Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients", 
    "pagination": "8", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049557045"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2407-8-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18194582"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2407-8-8", 
      "https://app.dimensions.ai/details/publication/pub.1049557045"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_458.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2407-8-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-8-8'


 

This table displays all metadata directly associated to this object as RDF triples.

258 TRIPLES      22 PREDICATES      112 URIs      103 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2407-8-8 schema:about N0498ad13dc1045d88104131a3cbb1e36
2 N159be2d4484343638c1fb425544f8a0a
3 N178fb8b9384b439f9221ddd709009824
4 N2113788fbb6148cc9333f1a1b63eb08e
5 N2af18818e99b4d09b876163f1fe5044a
6 N3c2f09c6de41472fb1d6d6cc88f6d821
7 N42fd62edf2b6429ea687086d27c41d26
8 N46eef873958d499eb9cef3c3130cf427
9 N4fd9bf14d18e475dadf56b3b48628775
10 N542d0691c4bc486e810cf815fd360a6a
11 N594d5e1b02c141118a26067ec7af7b8b
12 N6828474bdcdd46cc881ccba3e996138b
13 N9874aaeb684e4ab7a3ca5ae5bc3acce8
14 Nb0626b2d22bc4b6a8acda42d0d44044b
15 Ndb49d847c98f41e0bf6c49315ddcb94a
16 Ne9f4cfa79df44acb86a9bfb7d9352aa7
17 Nf180676f1de44de2995ec06c0f522914
18 Nff6ad37d39d944c29987e98da0f187ac
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author N9f11eef038164d858fad0d1d0a732caa
22 schema:citation sg:pub.10.1038/sj.bjc.6601378
23 schema:datePublished 2008-01-15
24 schema:datePublishedReg 2008-01-15
25 schema:description BackgroundThe objectives of this study were to evaluate long-term results of concurrent chemoradiotherapy (CRT) with 5-fluorouracil and cisplatin and the potential benefit of consolidation chemotherapy in patients with anal squamous cell carcinoma (ASCC).MethodsBetween January 1995 and February 2006, 31 patients with ASCC were treated with CRT. Radiotherapy was administered at 45 Gy over 5 weeks, followed by a boost of 9 Gy to complete or partial responders. Chemotherapy consisted of 5-fluorouracil (750 or 1,000 mg/m2) daily on days 1 to 5 and days 29 to 33; and, cisplatin (75 or 100 mg/m2) on day 2 and day 30. Twelve patients had T3–4 disease, whereas 18 patients presented with lymphadenopathy. Twenty-one (67.7%) received consolidation chemotherapy with the same doses of 5-fluorouracil and cisplatin, repeated every 4 weeks for maximum 4 cycles.ResultsNineteen patients (90.5%) completed all four courses of consolidation chemotherapy. After CRT, 28 patients showed complete responses, while 3 showed partial responses. After a median follow-up period of 72 months, the 5-year overall, disease-free, and colostomy-free survival rates were 84.7%, 82.9% and 96.6%, demonstrating that CRT with 5-fluorouracil and cisplatin yields a good outcome in terms of survival and sphincter preservation. No differences in 5-year OS and DFS rates between patients treated with CRT alone and CRT with consolidation chemotherapy was observed.Conclusionour study shows that CRT with 5-FU and cisplatin, with or without consolidation chemotherapy, was well tolerated and proved highly encouraging in terms of long-term survival and the preservation of anal function in ASCC. Further trials with a larger patient population are warranted in order to evaluate the potential role of consolidation chemotherapy.
26 schema:genre article
27 schema:inLanguage en
28 schema:isAccessibleForFree true
29 schema:isPartOf N3373b2e3caea4db28131eebc6bbf39ab
30 Nf950d009d4ab4876ad46e51b7ced8e00
31 sg:journal.1024632
32 schema:keywords BackgroundThe objective
33 ConclusionOur study
34 DFS rates
35 Overall
36 ResultsNineteen patients
37 T3-4 disease
38 anal function
39 anal squamous cell carcinoma
40 benefits
41 better outcomes
42 boost
43 carcinoma
44 cell carcinoma
45 chemoradiotherapy
46 chemotherapy
47 cisplatin
48 colostomy-free survival rates
49 complete response
50 concurrent chemoradiotherapy
51 consolidation chemotherapy
52 course
53 cycle
54 day 1
55 day 2
56 day 29
57 day 30
58 differences
59 disease
60 doses
61 follow
62 function
63 further trials
64 larger patient population
65 long-term results
66 long-term survival
67 lymphadenopathy
68 median follow
69 months
70 objective
71 order
72 outcomes
73 partial responders
74 partial response
75 patient population
76 patients
77 period
78 population
79 potential benefits
80 potential role
81 preservation
82 radiotherapy
83 rate
84 responders
85 response
86 results
87 role
88 same doses
89 sphincter preservation
90 squamous cell carcinoma
91 study
92 survival
93 survival rate
94 terms
95 terms of survival
96 trials
97 weeks
98 yield
99 schema:name Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
100 schema:pagination 8
101 schema:productId N4d81854957cb48a9893f8fbcd2f5ea6e
102 N50366a3d3a0746e5a938608dfcc0d770
103 N831ddf5006ce416db814c003c8536764
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049557045
105 https://doi.org/10.1186/1471-2407-8-8
106 schema:sdDatePublished 2022-05-20T07:24
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N68ea1796387b4cd38f9e9dfbc69cdaa6
109 schema:url https://doi.org/10.1186/1471-2407-8-8
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N0498ad13dc1045d88104131a3cbb1e36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Treatment Outcome
115 rdf:type schema:DefinedTerm
116 N05b3dbcb504240d086fdee93e0061ee4 rdf:first sg:person.0767622633.82
117 rdf:rest N1eec306f849846478bec0b7608edbd5a
118 N159be2d4484343638c1fb425544f8a0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Middle Aged
120 rdf:type schema:DefinedTerm
121 N178fb8b9384b439f9221ddd709009824 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Male
123 rdf:type schema:DefinedTerm
124 N1eec306f849846478bec0b7608edbd5a rdf:first sg:person.012631625664.47
125 rdf:rest N2d1a926d977f4a5eada31b1b752bb919
126 N2113788fbb6148cc9333f1a1b63eb08e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Survival Rate
128 rdf:type schema:DefinedTerm
129 N2af18818e99b4d09b876163f1fe5044a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Adult
131 rdf:type schema:DefinedTerm
132 N2d1a926d977f4a5eada31b1b752bb919 rdf:first sg:person.016554426212.74
133 rdf:rest Nde1ed071d98046d4b08cc02c68c8976b
134 N3373b2e3caea4db28131eebc6bbf39ab schema:issueNumber 1
135 rdf:type schema:PublicationIssue
136 N3c2f09c6de41472fb1d6d6cc88f6d821 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Dose-Response Relationship, Drug
138 rdf:type schema:DefinedTerm
139 N42fd62edf2b6429ea687086d27c41d26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Female
141 rdf:type schema:DefinedTerm
142 N46eef873958d499eb9cef3c3130cf427 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Anus Neoplasms
144 rdf:type schema:DefinedTerm
145 N4d81854957cb48a9893f8fbcd2f5ea6e schema:name pubmed_id
146 schema:value 18194582
147 rdf:type schema:PropertyValue
148 N4fd9bf14d18e475dadf56b3b48628775 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Cisplatin
150 rdf:type schema:DefinedTerm
151 N50366a3d3a0746e5a938608dfcc0d770 schema:name dimensions_id
152 schema:value pub.1049557045
153 rdf:type schema:PropertyValue
154 N542d0691c4bc486e810cf815fd360a6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 N594d5e1b02c141118a26067ec7af7b8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Follow-Up Studies
159 rdf:type schema:DefinedTerm
160 N6828474bdcdd46cc881ccba3e996138b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Time Factors
162 rdf:type schema:DefinedTerm
163 N68ea1796387b4cd38f9e9dfbc69cdaa6 schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 N831ddf5006ce416db814c003c8536764 schema:name doi
166 schema:value 10.1186/1471-2407-8-8
167 rdf:type schema:PropertyValue
168 N953737cdc9d94557bdc315897dc0a866 rdf:first sg:person.010673374672.49
169 rdf:rest Na5a28b7ca9184748851cbba3007d4009
170 N9874aaeb684e4ab7a3ca5ae5bc3acce8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Aged
172 rdf:type schema:DefinedTerm
173 N9f11eef038164d858fad0d1d0a732caa rdf:first sg:person.013035643562.16
174 rdf:rest N953737cdc9d94557bdc315897dc0a866
175 Na5a28b7ca9184748851cbba3007d4009 rdf:first sg:person.0772340340.61
176 rdf:rest N05b3dbcb504240d086fdee93e0061ee4
177 Nb0626b2d22bc4b6a8acda42d0d44044b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Fluorouracil
179 rdf:type schema:DefinedTerm
180 Nd85412c08990447c991f854910269def rdf:first sg:person.01034544570.10
181 rdf:rest rdf:nil
182 Ndb49d847c98f41e0bf6c49315ddcb94a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Antineoplastic Combined Chemotherapy Protocols
184 rdf:type schema:DefinedTerm
185 Nde1ed071d98046d4b08cc02c68c8976b rdf:first sg:person.0661267733.85
186 rdf:rest Nd85412c08990447c991f854910269def
187 Ne9f4cfa79df44acb86a9bfb7d9352aa7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Dose-Response Relationship, Radiation
189 rdf:type schema:DefinedTerm
190 Nf180676f1de44de2995ec06c0f522914 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Carcinoma, Squamous Cell
192 rdf:type schema:DefinedTerm
193 Nf950d009d4ab4876ad46e51b7ced8e00 schema:volumeNumber 8
194 rdf:type schema:PublicationVolume
195 Nff6ad37d39d944c29987e98da0f187ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Disease-Free Survival
197 rdf:type schema:DefinedTerm
198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical and Health Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
202 schema:name Oncology and Carcinogenesis
203 rdf:type schema:DefinedTerm
204 sg:journal.1024632 schema:issn 1471-2407
205 schema:name BMC Cancer
206 schema:publisher Springer Nature
207 rdf:type schema:Periodical
208 sg:person.01034544570.10 schema:affiliation grid-institutes:grid.15444.30
209 schema:familyName Kim
210 schema:givenName Nam Kyu
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034544570.10
212 rdf:type schema:Person
213 sg:person.010673374672.49 schema:affiliation grid-institutes:grid.15444.30
214 schema:familyName Ahn
215 schema:givenName Joong Bae
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010673374672.49
217 rdf:type schema:Person
218 sg:person.012631625664.47 schema:affiliation grid-institutes:grid.15444.30
219 schema:familyName Kim
220 schema:givenName Joo Hang
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012631625664.47
222 rdf:type schema:Person
223 sg:person.013035643562.16 schema:affiliation grid-institutes:grid.15444.30
224 schema:familyName Cho
225 schema:givenName Byoung Chul
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013035643562.16
227 rdf:type schema:Person
228 sg:person.016554426212.74 schema:affiliation grid-institutes:grid.15444.30
229 schema:familyName Chung
230 schema:givenName Hyun Cheol
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74
232 rdf:type schema:Person
233 sg:person.0661267733.85 schema:affiliation grid-institutes:grid.15444.30
234 schema:familyName Sohn
235 schema:givenName Joo Hyuk
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661267733.85
237 rdf:type schema:Person
238 sg:person.0767622633.82 schema:affiliation grid-institutes:grid.15444.30
239 schema:familyName Roh
240 schema:givenName Jae Kyung
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82
242 rdf:type schema:Person
243 sg:person.0772340340.61 schema:affiliation grid-institutes:grid.15444.30
244 schema:familyName Seong
245 schema:givenName Jinsil
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772340340.61
247 rdf:type schema:Person
248 sg:pub.10.1038/sj.bjc.6601378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007692399
249 https://doi.org/10.1038/sj.bjc.6601378
250 rdf:type schema:CreativeWork
251 grid-institutes:grid.15444.30 schema:alternateName Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
252 Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea
253 Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea
254 schema:name Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
255 Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea
256 Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea
257 Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
258 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...